Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication

Blood Cancer J. 2022 Mar 29;12(3):48. doi: 10.1038/s41408-022-00644-2.

Yu-Jia Huo^#¹, Peng-Peng Xu^#¹, Di Fu^#¹, Hong-Mei Yi^#², Yao-Hui Huang¹, Li Wang^{1

3}, Nan Wang¹, Meng-Meng Ji¹, Qing-Xiao Liu², Qing Shi¹, Shuo Wang¹, Shu Cheng¹, Yan Feng⁴, Wei-Li Zhao^{5

6}

¹ Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Pathology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Laboratory of Molecular Pathology, Shanghai, China.
⁴ State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
⁵ Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zhao.weili@yahoo.com.
⁶ Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Laboratory of Molecular Pathology, Shanghai, China. zhao.weili@yahoo.com.

^# Contributed equally.

No abstract available

Publication types